Welcome to visitJiangsu High-wit Medical Ltd.Enterprise official website
05
2023
-
12
Haizhi Biotechnology received an on-site investigation from the Beijing Adverse Drug Reaction Monitoring Center.
Haizhi Biotechnology accepted on-site research from the Beijing Adverse Drug Reaction Monitoring Center.
In order to implement the relevant spirit of the "14th Five-Year Plan for National Drug Safety and Promotion of High-Quality Development" and the "State Drug Administration's Opinions on Further Strengthening the Drug Adverse Reaction Monitoring System and Capacity Building," and to effectively monitor adverse events of medical devices and adverse reactions of cosmetics in Beijing, the Beijing Adverse Drug Reaction Monitoring Center organized relevant personnel to conduct research in Jiangsu Province at the end of November on the experience of monitoring medical device alerts, extracting risk signals from medical device adverse event monitoring, key monitoring of medical device adverse events, and monitoring of cosmetic adverse reactions. Our company undertook the on-site research work entrusted by the Jiangsu Bureau on November 28 and had in-depth exchanges with relevant regulatory personnel from Beijing and Jiangsu on the monitoring and collection of product adverse reactions.
Haizhi Biotechnology's cautious and rigorous attitude towards products and management norms has been recognized by relevant departments.
About Haizhi Biotechnology: Jiangsu Haizhi Biotechnology Co., Ltd. is located in Nanjing Jiangbei New District (referred to as: Haizhi Biotechnology). It is a comprehensive high-tech enterprise integrating R&D, production, and sales. The company focuses on the repair of skin and mucosal injuries, with a layout in transdermal drug delivery and skin and mucosal health care. Currently, the main business is the R&D, production, and sales of a series of products such as medical devices and cosmetics. The company has established a complete range of Class II medical devices and functional skincare products, and is advancing into Class III medical devices and drug-device combinations, preparing for industrialization. Haizhi Biotechnology has successively obtained a series of independent research and development achievements, applied for 27 patents, registered 76 trademarks, and registered more than 20 Class II medical device products. Since 2018, it has been recognized as a private technology enterprise in Jiangsu Province, a national/Jiangsu Province/Nanjing City high-tech enterprise, a technology-based small and medium-sized enterprise, and a "specialized, refined, distinctive, and innovative" small and medium-sized enterprise in Nanjing.
More news
Address: Building B2, No.9 Kechuang Avenue, Jiangbei New District, Nanjing
High-wit Micro Mall
High-wit official website